Nghiên cứu về gene tiền ung thư HER-2/neu trong ung thư vú và buồng trứng ở người

10.1126/science.3289120

BACUS, S, THE EVALUATION OF ESTROGEN-RECEPTOR IN PRIMARY BREAST-CARCINOMA BY COMPUTER-ASSISTED IMAGE-ANALYSIS, AMERICAN JOURNAL OF CLINICAL PATHOLOGY 90: 233 (1988).

10.1016/0092-8674(86)90779-8

BARGMANN, C.I., ONCOGENIC ACTIVATION OF THE NEU-ENCODED RECEPTOR PROTEIN BY POINT MUTATION AND DELETION, EMBO JOURNAL 7: 2043 (1988).

BARNES, D.M., AN IMMUNOHISTOCHEMICAL EVALUATION OF C-ERB-2 EXPRESSION IN HUMAN-BREAST CARCINOMA, BRITISH JOURNAL OF CANCER 58: 448 (1988).

BATTIFORA, H, CLINICAL-APPLICATIONS OF THE IMMUNOHISTOCHEMISTRY OF FILAMENTOUS PROTEINS, AMERICAN JOURNAL OF SURGICAL PATHOLOGY 12: 24 (1988).

BATTIFORA, H, THE INFLUENCE OF PROTEASE DIGESTION AND DURATION OF FIXATION ON THE IMMUNOSTAINING OF KERATINS - A COMPARISON OF FORMALIN AND ETHANOL FIXATION, JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY 34: 1095 (1986).

BERGER, M.S., CORRELATION OF C-ERBB-2-GENE AMPLIFICATION AND PROTEIN EXPRESSION IN HUMAN-BREAST CARCINOMA WITH NODAL STATUS AND NUCLEAR GRADING, CANCER RESEARCH 48: 1238 (1988).

10.1146/annurev.bi.52.070183.001505

10.1126/science.2999974

DAY, T. G., NATIONAL CANCER INSTITUTE MONOGRAPHS 42: 15 (1975).

10.1126/science.2885917

GUSTERSON, B.A., C-ERBB-2 EXPRESSION IN BENIGN AND MALIGNANT BREAST DISEASE, BRITISH JOURNAL OF CANCER 58: 453 (1988).

GUSTERSON, B.A., MOLECULAR AND CELLULAR PROBES 1: 383 (1987).

HOLT, J.A., ESTROGEN AND PROGESTIN BINDING IN CYTOSOLS OF OVARIAN ADENOCARCINOMAS, OBSTETRICS AND GYNECOLOGY 53: 50 (1979).

HUDZIAK, R.M., INCREASED EXPRESSION OF THE PUTATIVE GROWTH-FACTOR RECEPTOR P185HER2 CAUSES TRANSFORMATION AND TUMORIGENESIS OF NIH-3T3 CELLS, PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 84: 7159 (1987).

Koss, L. G., Diagnostic Cytology and its Histopathologic Bases: 991 (1979).

Linsk, J. A., Clinical Aspiration Cytology: 105 (1983).

MULLER, W.J., SINGLE-STEP INDUCTION OF MAMMARY ADENOCARCINOMA IN TRANSGENIC MICE BEARING THE ACTIVATED C-NEU ONCOGENE, CELL 54: 105 (1988).

PRESS, M.F., LOCALIZATION OF PROGESTERONE-RECEPTOR WITH MONOCLONAL-ANTIBODIES TO THE HUMAN PROGESTIN RECEPTOR, ENDOCRINOLOGY 122: 1165 (1988).

PRESS, M.F., METHODS IN LABORATORY INVESTIGATION - AN IMMUNOCYTOCHEMICAL METHOD FOR DEMONSTRATING ESTROGEN-RECEPTOR IN HUMAN-UTERUS USING MONOCLONAL-ANTIBODIES TO HUMAN ESTROPHILIN, LABORATORY INVESTIGATION 50: 480 (1984).

PRESS, M.F., IMMUNOCYTOCHEMICAL IDENTIFICATION OF ESTROGEN-RECEPTOR IN OVARIAN CARCINOMAS - LOCALIZATION WITH MONOCLONAL ESTROPHILIN ANTIBODIES COMPARED WITH BIOCHEMICAL ASSAYS, LABORATORY INVESTIGATION 53: 349 (1985).

SCHECHTER, A.L., THE NEU ONCOGENE - AN ERB-B-RELATED GENE ENCODING A 185,000-MR TUMOR-ANTIGEN, NATURE 312: 513 (1984).

10.1038/290261a0

10.3322/canjclin.39.1.3

SLAMON, D.J., CANCER CELLS 7: 371 (1989).

SLAMON, D.J., PROTOONCOGENES AND HUMAN CANCERS, NEW ENGLAND JOURNAL OF MEDICINE 317: 955 (1987).

10.1126/science.6538699

SLAMON, D.J., IDENTIFICATION AND CHARACTERIZATION OF THE PROTEIN ENCODED BY THE HUMAN N-MYC ONCOGENE, SCIENCE 232: 768 (1986).

10.1126/science.3014652

10.1126/science.3798106

SLAMON, D.J., AMPLIFICATION OF C-ERBB-2 AND AGGRESSIVE HUMAN-BREAST TUMORS - RESPONSE, SCIENCE 240: 1796 (1988).

Sternberger, L. A., Immunocytochemistry: 211 (1986).

TANAKA, T, EXPRESSION OF P21 RAS ONCOPROTEINS IN HUMAN CANCERS, CANCER RESEARCH 46: 1465 (1986).

VANDEVIJVER, M, AMPLIFICATION OF THE NEU (C-ERBB-2) ONCOGENE IN HUMAN MAMMARY-TUMORS IS RELATIVELY FREQUENT AND IS OFTEN ACCOMPANIED BY AMPLIFICATION OF THE LINKED C-ERBA ONCOGENE, MOLECULAR AND CELLULAR BIOLOGY 7: 2019 (1987).

VANDEVIJVER, M.J., AMPLIFICATION AND OVER-EXPRESSION OF THE NEU ONCOGENE IN HUMAN-BREAST CARCINOMAS, EUROPEAN JOURNAL OF SURGICAL ONCOLOGY 14: 111 (1988).

VANDEVIJVER, M.J., NEU-PROTEIN OVEREXPRESSION IN BREAST-CANCER - ASSOCIATION WITH COMEDO-TYPE DUCTAL CARCINOMA INSITU AND LIMITED PROGNOSTIC VALUE IN STAGE-II BREAST-CANCER, NEW ENGLAND JOURNAL OF MEDICINE 319: 1239 (1988).

VARLEY, J.M., ALTERATIONS TO EITHER C-ERB-2 (NEU)-PROTO-ONCOGENE OR C-MYC-PROTO-ONCOGENE IN BREAST CARCINOMAS CORRELATE WITH POOR SHORT-TERM PROGNOSIS, ONCOGENE 1: 423 (1987).

VARMUS, H.E., THE MOLECULAR-GENETICS OF CELLULAR ONCOGENES, ANNUAL REVIEW OF GENETICS 18: 553 (1984).

VENTER, D.J., OVEREXPRESSION OF THE C-ERBB-2 ONCOPROTEIN IN HUMAN-BREAST CARCINOMAS - IMMUNOHISTOLOGICAL ASSESSMENT CORRELATES WITH GENE AMPLIFICATION, LANCET 2: 69 (1987).

WRIGHT, C, EXPRESSION OF C-ERBB-2 ONCOPROTEIN - A PROGNOSTIC INDICATOR IN HUMAN-BREAST CANCER, CANCER RESEARCH 49: 2087 (1989).

YOKOTA, J, ALTERED EXPRESSION OF THE RETINOBLASTOMA (RB) GENE IN SMALL-CELL CARCINOMA OF THE LUNG, ONCOGENE 3: 471 (1988).

Young, R. C., Cancer: Principles and Practices of Oncology: 1083 (1985).

ZHOU, D.J., PROTO-ONCOGENE ABNORMALITIES IN HUMAN-BREAST CANCER - C-ERBB-2 AMPLIFICATION DOES NOT CORRELATE WITH RECURRENCE OF DISEASE, ONCOGENE 4: 105 (1989).

ZHOU, D.J., ASSOCIATION OF MULTIPLE COPIES OF THE C-ERBB-2 ONCOGENE WITH SPREAD OF BREAST-CANCER, CANCER RESEARCH 47: 6123 (1987).